トランスキャセータによるミトラ弁と三弁の修復におけるリスク分層化のための修飾されたエッセンシャルフレリティツールセット
Matthieu Schäfer1, Clemens Metze2, Caroline F Hasse2
1University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany. matthieu.schaefer@uk-koeln.de.
まとめ
エッセンシャル・フレリティ・ツールセット (EFT) は,トランスキャテーテルによるミトラルおよび三弁修復 (TMTVR) の患者の死亡リスクを効果的に予測します. EFTと多次元の予後指数 (MPI) を組み合わせた段階的なアプローチは,より良い治療決定のためのリスク層分化をさらに精密にします.
科学分野:
- 心臓病学 心臓病学
- ゲリアトリクス ゲリアトリクス
- 医療サービス 研究 医療サービス
背景:
- トランスキャテーターミトラルおよび三弁修復 (TMTVR) 候補者のリスク分層化のために,脆弱性評価が推奨されます.
- この患者集団の最適な脆弱性スコアは未決定のままです.
研究 の 目的:
- TMTVRを受ける患者において,改変されたEssential Frailty Toolset (EFT) の予後値を評価する.
- リスクの階層化を強化するために,EFTと多次元予測指数 (MPI) を組み合わせた段階的なアプローチの有用性を調査する.
主な方法:
- 206人のTMTVR患者の遡及的分析.
- 歩行速度,認知障害,ヘモグロビン,血清アルブミンに基づいて,改変されたエッセンシャル・フレリティ・ツールセット (EFT) の計算.
- コックスの比例リスクモデルで,EFTの弱さと全原因死亡率の関連性を評価する.
主要な成果:
- EFTは予後的な価値を示し,不妊および不妊の患者で死亡リスクの増加が観察されました.
- EFTとMPIを用いた段階的なアプローチにより,2年間の死亡率の4.4倍の差を伴う2つのリスクカテゴリーが特定されました.
- EFTと死亡率との関連は,他のリスク要因を調整した後も維持されたが,MPIによって弱まった.
結論:
- エッセンシャル・フレリティ・ツールセット (EFT) は,TMTVR候補者の初期脆弱性評価のための貴重なシンプルなツールです.
- 弱体期前の患者でEFTの段階的な適用に続いてMPIを適用すると,リスクの階層化を大幅に改善することができます.
- このアプローチは,TMTVRの手続きの治療的意思決定を助けます.
関連する概念動画
01:22Mitral Valve Prolapse II: Assessment and Management
710
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
710
01:26Mitral Stenosis III: Medical Management
322
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
322
01:27Mitral Valve Prolapse I: Introduction
625
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
625
01:19Mitral Valve Prolapse III: Nursing Management
430
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
430
01:27Mitral Stenosis IV: Nursing Management
300
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
300
01:25Mitral Regurgitation III: Medical Management
403
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
403